The FDA said it is making 'enhancements' designed to help states develop programs for importing cheaper drugs from Canada.

Eikon Therapeutics is laying off staff for the second time in 19 months, responding to 'changes in external circumstances' ...

The FDA's Oncologic Drugs Advisory Committee on Wednesday voted 5 to 4 against UroGen’s mitomycin as an option for low-grade ...

The FDA’s On­co­log­ic Drugs Ad­vi­so­ry Com­mit­tee vot­ed 8-0 against a new in­di­ca­tion for Pfiz­er’s Talzen­na in com­bi­na­tion with Xtan­di for first-line treat­ment of adults with … Get free ...

Genentech signs $105M upfront deal with Orionis Biosciences to develop molecular glue cancer drugs, with potential milestones ...

BioNTech to invest £1B in UK R&D over 10 years, receives £129M government grant to build research centers and HQ in London, ...

Altos, led by industry stalwarts Hal Barron and Hans Bishop, brought Dorian Therapeutics into its fold this week, according ...

Mod­er­na pulls BLA for its Covid-flu shot: The com­pa­ny sug­gest­ed on its most re­cent … Get free access to a limited ...

Weill Cornell Medicine study shows cocaine vaccine triggers antibodies & reduces drug use in small trial, but effects modest.

Juvenescence is out with a $76 million Series B-1, its first equity funding since before the Covid-19 pandemic.

ReproNovo raises $65M for trials of leflutrozole and nolasiban in reproductive health. CEO Jean Marie Duvall plans Phase 2 ...

Duncan Reece shares why his dementia care startup Veronica Health closed before seeing patients, citing fundraising challenges and investor skepticism of value-based care.